Michael G. Grey, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 7,500 shares at $104.27 ($782K) on 2015-11-16, disclosed to the SEC on 2015-11-18.
Scheduled sale ($782k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |